ACADIA PHARMACEUTICALS INC. (ACAD) Operating cash flow 2016–2025
ACADIA PHARMACEUTICALS INC. (ACAD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$109.8MFY2025 · since FY2016: -$208.4M → $109.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $109.8M | -30.4% |
| FY2024 | $157.7M | +844.3% |
| FY2023 | $16.7M | +114.6% |
| FY2022 | -$114.0M | +9.3% |
| FY2021 | -$125.7M | +7.7% |
| FY2020 | -$136.2M | +9.9% |
| FY2019 | -$151.1M | +9.8% |
| FY2018 | -$167.5M | +23.1% |
| FY2017 | -$217.8M | -4.5% |
| FY2016 | -$208.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACAD financial trends
ACAD RevenueACAD Net incomeACAD Net marginACAD Gross profitACAD Gross marginACAD Operating incomeACAD Operating marginACAD Free cash flowACAD Capital expendituresACAD Return on equityACAD Stock buybacksACAD Dividends paidACAD Total assetsACAD Total liabilitiesACAD Shareholders’ equityACAD overview →